SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 94 filers reported holding SERES THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 3.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $265 | -44.7% | 342,200 | 0.0% | 0.01% | -50.0% |
| Q4 2023 | $479 | -41.2% | 342,200 | 0.0% | 0.01% | -45.5% |
| Q3 2023 | $814 | -35.2% | 342,200 | +30.4% | 0.02% | -33.3% |
| Q2 2023 | $1,257 | -15.5% | 262,325 | 0.0% | 0.03% | -17.5% |
| Q1 2023 | $1,487 | +0.2% | 262,325 | -1.0% | 0.04% | -4.8% |
| Q4 2022 | $1,484 | -99.9% | 265,000 | +33.2% | 0.04% | +10.5% |
| Q3 2022 | $1,278,000 | +87.1% | 199,000 | 0.0% | 0.04% | +81.0% |
| Q2 2022 | $683,000 | +53.5% | 199,000 | +218.7% | 0.02% | +75.0% |
| Q1 2022 | $445,000 | -14.4% | 62,450 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $520,000 | +19.5% | 62,450 | 0.0% | 0.01% | +9.1% |
| Q3 2021 | $435,000 | -70.8% | 62,450 | 0.0% | 0.01% | -70.3% |
| Q2 2021 | $1,489,000 | – | 62,450 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $131,073,645 | 5.09% |
| Lion Point Capital, LP | 596,803 | $3,383,873 | 1.39% |
| Eversept Partners, LP | 2,536,665 | $14,382,891 | 1.00% |
| Knott David M Jr | 315,000 | $1,786 | 0.70% |
| Kynam Capital Management, LP | 768,913 | $4,359,737 | 0.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,525 | $1,318,417 | 0.54% |
| Simplify Asset Management Inc. | 550,626 | $3,122,049 | 0.45% |
| Atom Investors LP | 90,388 | $512,500 | 0.28% |
| FEDERATED HERMES, INC. | 15,277,356 | $86,622,609 | 0.22% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 47,796 | $271,003 | 0.17% |